292 results on '"Olafsen, Tove"'
Search Results
2. Multimodality PET and Near-Infrared Fluorescence Intraoperative Imaging of CEA-Positive Colorectal Cancer
3. A comprehensive preclinical study supporting clinical trial of oncolytic chimeric poxvirus CF33-hNIS-anti-PD-L1 to treat breast cancer
4. Identification of miRNA signatures associated with radiation-induced late lung injury in mice
5. Figure S4 from 89Zr-ImmunoPET for the Specific Detection of EMP2-Positive Tumors
6. Data from 89Zr-ImmunoPET for the Specific Detection of EMP2-Positive Tumors
7. Supplemental Tables from 89Zr-ImmunoPET for the Specific Detection of EMP2-Positive Tumors
8. Supplementary Data from 89Zr-ImmunoPET for the Specific Detection of EMP2-Positive Tumors
9. Multimodal imaging guides surgical management in a preclinical spinal implant infection model
10. 89Zr-ImmunoPET for the Specific Detection of EMP2-Positive Tumors
11. Abstract A088: Radiopharmaceutical therapy for pancreatic cancer: Engineered anti-prostate stem cell antigen (PSCA) antibody demonstrates targeted imaging and antitumor effects in a syngeneic mouse model of pancreatic ductal adenocarcinoma (PDAC)
12. Immuno-PET of Murine T Cell Reconstitution Postadoptive Stem Cell Transplantation Using Anti-CD4 and Anti-CD8 Cys-Diabodies
13. Engineered antibody fragments for immuno-PET imaging of endogenous CD8+ T cells in vivo
14. Positron Emission Tomography Imaging of Endometrial Cancer Using Engineered Anti-EMP2 Antibody Fragments
15. Levels of murine, but not human, CXCL13 are greatly elevated in NOD-SCID mice bearing the AIDS-associated Burkitt lymphoma cell line, 2F7.
16. Targeting CEA in Pancreas Cancer Xenografts with a Mutated scFv-Fc Antibody Fragment
17. CA19-9 as a Potential Target for Radiolabeled Antibody-Based Positron Emission Tomography of Pancreas Cancer
18. Evaluation of Two Internalizing Carcinoembryonic Antigen Reporter Genes for Molecular Imaging
19. An affinity matured minibody for PET imaging of prostate stem cell antigen (PSCA)-expressing tumors
20. Characterization of an engineered human purine nucleoside phosphorylase fused to an anti-her2/neu single chain Fv for use in ADEPT
21. Targeted alpha therapy with astatine-211-labeled anti-PSCA A11 minibody shows antitumor efficacy in prostate cancer xenografts and bone microtumors
22. Covalent disulfide‐linked anti‐CEA diabody allows site‐specific conjugation and radiolabeling for tumor targeting applications
23. Supplementary Data from The PET-Tracer 89Zr-Df-IAB22M2C Enables Monitoring of Intratumoral CD8 T-cell Infiltrates in Tumor-Bearing Humanized Mice after T-cell Bispecific Antibody Treatment
24. Data from The PET-Tracer 89Zr-Df-IAB22M2C Enables Monitoring of Intratumoral CD8 T-cell Infiltrates in Tumor-Bearing Humanized Mice after T-cell Bispecific Antibody Treatment
25. Figure S2 from The PET-Tracer 89Zr-Df-IAB22M2C Enables Monitoring of Intratumoral CD8 T-cell Infiltrates in Tumor-Bearing Humanized Mice after T-cell Bispecific Antibody Treatment
26. Supporting Information from Optimizing Radiolabeled Engineered Anti-p185HER2 Antibody Fragments for In vivo Imaging
27. Heart Uptake of [18F]Fluoro-4-Thia-Oleate in a Non-Alcoholic Fatty Liver Disease Mouse Model
28. Imaging Tumor Xenografts Using Radiolabeled Antibodies
29. Generation of Single-Chain Fv Fragments and Multivalent Derivatives scFv-Fc and scFv-CH3 (Minibodies)
30. Engineering of the Fc Region for Improved PK (FcRn Interaction)
31. Engineered antibody fragments for immuno-PET imaging of endogenous CD8 + T cells in vivo
32. Safety and Biodistribution Profile of Poly(styrenyl acetal trehalose) and Its Granulocyte Colony Stimulating Factor Conjugate
33. Biodistribution of Intra-Arterial and Intravenous Delivery of Human Umbilical Cord Mesenchymal Stem Cell-Derived Extracellular Vesicles in a Rat Model to Guide Delivery Strategies for Diabetes Therapies
34. Dual-labeled anti-CEA antibody for near-infrared fluorescence and PET imaging of colorectal cancer
35. PET imaging and treatment of pancreatic cancer peritoneal carcinomatosis after subcutaneous intratumoral administration of a novel oncolytic virus, CF33-hNIS-antiPDL1
36. A comprehensive preclinical study supporting clinical trial of oncolytic chimeric poxvirus CF33-hNIS-anti-PD-L1 to treat breast cancer
37. Heart Uptake of [ 18 F]Fluoro-4-Thia-Oleate in a Non-Alcoholic Fatty Liver Disease Mouse Model.
38. Antibody Vectors for Imaging
39. Evaluation of an anti-p185 HER2 (scFv-C H2-C H3) 2 fragment following radioiodination using two different residualizing labels: SGMIB and IB-Mal- d-GEEEK
40. ImmunoPET using engineered antibody fragments: fluorine-18 labeled diabodies for same-day imaging
41. Recombinant carcinoembryonic antigen as a reporter gene for molecular imaging
42. Fusion of Gaussia Luciferase to an Engineered Anti-carcinoembryonic Antigen (CEA) Antibody for In Vivo Optical Imaging
43. Tunable pharmacokinetics: modifying the in vivo half-life of antibodies by directed mutagenesis of the Fc fragment
44. Fc Engineering: Serum Half-Life Modulation Through FcRn Binding
45. Complement-mediated lysis of cultured osteosarcoma cell lines using chimeric mouse/human TP-1 IgG1 and IgG3 antibodies
46. The PET-Tracer 89Zr-Df-IAB22M2C Enables Monitoring of Intratumoral CD8 T-cell Infiltrates in Tumor-Bearing Humanized Mice after T-cell Bispecific Antibody Treatment
47. Tuning the serum persistence of human serum albumin domain III: diabody fusion proteins
48. ImmunoPET imaging of B-cell lymphoma using 124I-anti-CD20 scFv dimers (diabodies)
49. Engineered humanized diabodies for microPET imaging of prostate stem cell antigen-expressing tumors
50. Bifunctional antibody-Renilla luciferase fusion protein for in vivo optical detection of tumors
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.